Clinical Trial Update: Sacituzumab Govitecan Combined With Head Radiotherapy for Her2-negative Breast Cancer Brain Metastases [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating sacituzumab govitecan combined with brain radiotherapy for HER2-negative breast cancer with brain metastases; the study is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Sacituzumab Govitecan (sacituzumab govitecan)

Snippet

Sponsor: Guangzhou Medical University | Conditions: Brain Metastasis | Phase 2 | Status: NOT_YET_RECRUITING